Our Services
Medical Information
Helpful Resources
Published on: 10/11/2026
Elevated ALT and AST together usually signal that liver cells are injured or inflamed, with common causes including fatty liver disease, alcohol use, viral hepatitis, certain medications or supplements, and autoimmune or genetic liver conditions. The AST/ALT ratio matters: a ratio near or above 2:1 often points toward alcohol-related liver damage, while ALT higher than AST is more typical of fatty liver or viral hepatitis. Not every cause is the liver, since strenuous exercise, muscle injury, thyroid disease, and celiac disease can also raise both enzymes, and mildly high results are sometimes harmless or temporary. How high the numbers are, whether they are rising, and whether you have symptoms like jaundice, dark urine, abdominal pain, or swelling all change how urgent the situation is. There are several important factors to consider, including when values become dangerous and what testing typically comes next, so see below for the complete answer.
Because abnormal ALT and AST results can mean anything from a minor, reversible issue to serious liver disease, the fastest way to make sense of your own numbers is to look at them alongside your symptoms, medications, and health history. A free, instant, online symptom check takes just a few minutes, asks the same kinds of questions a clinician would, and helps you see which causes best fit your situation. It can also tell you whether this warrants a routine follow-up or more prompt medical attention, so you walk into your next appointment with clearer questions and less guesswork.
Last reviewed for medical accuracy: 10/09/2026
Elevated liver enzymes—specifically alanine aminotransferase (ALT) and aspartate aminotransferase (AST)—often show up on routine blood tests. While seeing “alt and ast high” can feel alarming, understanding what these results mean can help you take the right next steps. This guide walks you through the basics, common causes, and when to seek further evaluation.
Both enzymes play roles in amino acid metabolism. High levels in blood tests signal tissue irritation or injury—most often in the liver.
Although reference ranges vary slightly by lab, typical values are:
Values just above these limits may not be worrisome, but sustained elevations or levels several times the upper limit deserve attention.
Seeing both ALT and AST high suggests liver-related causes in most cases. While AST can come from muscle and heart, a parallel rise with ALT points you toward the liver as the likely source of injury.
When muscle or heart sources are considered, your doctor may order additional tests (CK for muscle, troponin for heart).
Comparing AST to ALT helps narrow down causes:
This ratio is a clue, not a definitive answer. Clinical context and other tests are essential.
Minor enzyme elevations (up to 2–3× normal) sometimes normalize on their own. However, consider prompt medical evaluation if you have:
If you experience severe abdominal pain, confusion, or bleeding, seek emergency care immediately.
While specific treatment depends on the cause, general strategies include:
Your doctor will tailor treatment once the specific cause is identified.
Seeing “ALT and AST high” can be stressful. Here’s how to stay proactive without panic:
Elevated liver enzymes often respond well to appropriate interventions. However, if you have any of the following, see a healthcare provider promptly:
Always err on the side of caution—early diagnosis and treatment can prevent long-term liver damage.
Your liver is resilient, but it also needs support. By understanding what “alt and ast high” means, you can work with your healthcare team to protect your liver health and overall well-being. If you have concerns, don’t wait—reach out to a medical professional about anything that could be life threatening or serious.
(References)
* Akmal M, Massry SG. Reversible hepatic dysfunction associated with rhabdomyolysis. Am J Nephrol. 1990;10(1):49-52. doi: 10.1159/000168053. PMID: 2343880.
* Varga M, Sárváry E, Sulyok B, Perner F. [Follow-up on alpha-glutathione-S-transferase serum level following liver transplantation]. Orv Hetil. 1997 Feb 16;138(7):413-6. PMID: 9091842.
* Hsu CC, Lin CC, Liao TS, Yin MC. Protective effect of s-allyl cysteine and s-propyl cysteine on acetaminophen-induced hepatotoxicity in mice. Food Chem Toxicol. 2006 Mar;44(3):393-7. doi: 10.1016/j.fct.2005.08.012. Epub 2005 Sep 21. PMID: 16181716.
* Hsu CC, Lin KY, Wang ZH, Lin WL, Yin MC. Preventive effect of Ganoderma amboinense on acetaminophen-induced acute liver injury. Phytomedicine. 2008 Nov;15(11):946-50. doi: 10.1016/j.phymed.2008.04.011. Epub 2008 Jun 24. PMID: 18579359.
* Vagenas P, Di Paola A, Herme M, Lincoln T, Skiest DJ, Altice FL, Springer SA. An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone. J Subst Abuse Treat. 2014 Jul;47(1):35-40. doi: 10.1016/j.jsat.2014.02.008. Epub 2014 Mar 12. PMID: 24674234; PMCID: PMC4042403.
* Kızılyel O, Metin MS, Elmas ÖF, Çayır Y, Aktaş A. Effects of oral isotretinoin on lipids and liver enzymes in acne patients. Cutis. 2014 Nov;94(5):234-8. PMID: 25474452.
* Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017 Jan;112(1):18-35. doi: 10.1038/ajg.2016.517. Epub 2016 Dec 20. PMID: 27995906.
* Paulino MG, Rossi PA, Venturini FP, Tavares D, Elisabete da Silva Souza N, Sakuragui MM, Moraes G, Terezan AP, Fernandes JB, Giani A, Fernandes MN. Hepatotoxicity and metabolic effects of cellular extract of cyanobacterium Radiocystis fernandoi containing microcystins RR and YR on neotropical fish (Hoplias malabaricus). Chemosphere. 2017 May;175:431-439. doi: 10.1016/j.chemosphere.2017.02.089. Epub 2017 Feb 16. PMID: 28242458.
* Lei F, Liu YM, Zhou F, Qin JJ, Zhang P, Zhu L, Zhang XJ, Cai J, Lin L, Ouyang S, Wang X, Yang C, Cheng X, Liu W, Li H, Xie J, Wu B, Luo H, Xiao F, Chen J, Tao L, Cheng G, She ZG, Zhou J, Wang H, Lin J, Luo P, Fu S, Zhou J, Ye P, Xiao B, Mao W, Liu L, Yan Y, Liu L, Chen G, Li H, Huang X, Zhang BH, Yuan Y. Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China. Hepatology. 2020 Aug;72(2):389-398. doi: 10.1002/hep.31301. PMID: 32359177; PMCID: PMC7267515.
* Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, Schaefer E, Chung RT. Liver Biochemistries in Hospitalized Patients With COVID-19. Hepatology. 2021 Mar;73(3):890-900. doi: 10.1002/hep.31326. Epub 2020 Nov 4. PMID: 32415860.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.